Propafenone Hydrochloride Sr | Propafenone Hydrochloride Capsule, Extended Release while Breastfeeding

For most of the drugs advantages of taking medications overweighs the potential risks however some drugs could be really dangerous for breastfed baby hence every medication shall be considered separately. In this page we will discuss about purpose of Propafenone Hydrochloride Sr | Propafenone Hydrochloride Capsule, Extended Release and its risk associated with lactation. We will also discuss the usage of Propafenone Hydrochloride Sr | Propafenone Hydrochloride Capsule, Extended Release and some common side effects associated with Propafenone Hydrochloride Sr | Propafenone Hydrochloride Capsule, Extended Release.

Propafenone Hydrochloride extended-release (SR) capsules are indicated to prolong the time to recurrence of symptomatic atrial fibrillation (AF) in patients with episodic (most likely paroxysmal or persistent) AF who do not have structural heart disease. Usage Considerations: •The use of Propafenone Hydrochloride extended-release (SR) capsules in patients with permanent AF or in patients exclusively with atrial flutter or paroxysmal supraventricular tachycardia (PSVT) has not been evaluated. Do not use Propafenone Hydrochloride extended-release (SR) capsules to control ventricular rate during AF. •Some patients with atrial flutter treated with propafenone have developed 1:1 conduction, producing an increase in ventricular rate. Concomitant treatment with drugs that increase the functional atrioventricular (AV) nodal refractory period is recommended. •The effect of propafenone on mortality has not been determined [see Boxed Warning]. Propafenone Hydrochloride extended-release (SR) capsules are an antiarrhythmic indicated to prolong the time to recurrence of symptomatic atrial fibrillation (AF) in patients with episodic (most likely paroxysmal or persistent) AF who do not have structural heart disease. (1) Usage Considerations: •Use in patients with permanent atrial fibrillation or with atrial flutter or paroxysmal supraventricular tachycardia (PSVT) has not been evaluated. Do not use to control ventricular rate during atrial fibrillation. (1) •In patients with atrial fibrillation and atrial flutter, use Propafenone Hydrochloride extended-release (SR) capsules with drugs that increase the atrioventricular nodal refractory period. (1) •The effect of propafenone on mortality has not been determined. (1)